Ulrich Dührsen

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 28

Top Venues

Scientific reports

Cancer medicine

British journal of haematology

Mycoses

University Hospital Essen

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University Hospital Essen Sep 01 1998

Germany

Direcor / Univ.-Prof. Dr. med. :: Hematology

Publications

Hildegard Lax, Julia Baum, Nils Lehmann, Anja Merkel-Jens, Dietrich W Beelen, Karl-Heinz Jöckel, Ulrich Dührsen
Patterns of follow-up care in adult blood cancer survivors-Prospective evaluation of health-related outcomes, resource use, and quality of life. Cancer medicine 13 (7) (2024)
Christina Friese, Katharina Breuckmann, Andreas Hüttmann, Lewin Eisele, Ulrich Dührsen
Neutropenia-related aspergillosis in non-transplant haematological patients hospitalised under ambient air versus purified air conditions. Mycoses (2023)
Julia Baum, Hildegard Lax, Nils Lehmann, Anja Merkel-Jens, Dietrich W Beelen, Karl-Heinz Jöckel, Ulrich Dührsen
Patient-reported patterns of follow-up care in the 'Aftercare in Blood Cancer Survivors' (ABC) study. Journal of cancer research and clinical oncology (2023)
Julia Baum, Hildegard Lax, Nils Lehmann, Anja Merkel-Jens, Dietrich W Beelen, Karl-Heinz Jöckel, Ulrich Dührsen
Impairment of vocational activities and financial problems are frequent among German blood cancer survivors. Scientific reports 13 (1) (2023)
Julia Baum, Hildegard Lax, Nils Lehmann, Anja Merkel-Jens, Dietrich W Beelen, Karl-Heinz Jöckel, Ulrich Dührsen
Impairment of vocational activities and financial problems are frequent among German blood cancer survivors. Scientific reports 13 (1) (2023)
Julia Baum, Hildegard Lax, Nils Lehmann, Anja Merkel-Jens, Dietrich W Beelen, Karl-Heinz Jöckel, Ulrich Dührsen
Impairment of vocational activities and financial problems are frequent among German blood cancer survivors. Scientific reports 13 (1) (2023)
Christina Friese, Katharina Breuckmann, Andreas Hüttmann, Lewin Eisele, Ulrich Dührsen
Neutropenia-related aspergillosis in non-transplant hematological patients hospitalized under ambient air versus purified air conditions. Mycoses (2023)
Patricia Johansson, Stefan Alig, Julia Richter, Christine Hanoun, Jan Rekowski, Jan Dürig, Bauke Ylstra, Daphne de Jong, Wolfram Klapper, Ash A Alizadeh, Ulrich Dührsen, Andreas Hüttmann
Outcome prediction by interim positron emission tomography and IgM monoclonal gammopathy in diffuse large B-cell lymphoma. Annals of hematology (2023)
Julia Baum, Hildegard Lax, Nils Lehmann, Anja Merkel-Jens, Dietrich W Beelen, Karl-Heinz Jöckel, Ulrich Dührsen
Impairment of vocational activities and financial problems are frequent among German blood cancer survivors. Scientific reports 13 (1) (2023)
Pradeep Kumar Patnana, Longlong Liu, Daria Frank, Subbaiah Chary Nimmagadda, Matthias Behrens, Helal Ahmed, Xiaoqing Xie, Marie Liebmann, Lanying Wei, Andrea Gerdemann, Aniththa Thivakaran, Hans-Ulrich Humpf, Luisa Klotz, Martin Dugas, Julian Varghese, Marija Trajkovic-Arsic, Jens T Siveke, Helmut Hanenberg, Bertram Opalka, Ulrich Dührsen, Hans Christian Reinhardt, Ulrich Guenther, Nikolas von Bubnoff, Cyrus Khandanpour
Dose-dependent expression of GFI1 alters metabolism in the haematopoietic progenitors and MLL::AF9-induced leukaemic cells. British journal of haematology (2023)
Julia Baum, Hildegard Lax, Nils Lehmann, Anja Merkel-Jens, Dietrich W Beelen, Karl-Heinz Jöckel, Ulrich Dührsen
Impairment of vocational activities and financial problems are frequent among German blood cancer survivors. Scientific reports 13 (1) (2023)
Robert Seifert, David Kersting, Christoph Rischpler, Patrick Sandach, Justin Ferdinandus, Wolfgang P Fendler, Kambiz Rahbar, Matthias Weckesser, Lale Umutlu, Christine Hanoun, Andreas Huettmann, Hans Christian Reinhardt, Bastian von Tresckow, Ken Herrmann, Ulrich Dührsen, Michael Schäfers
Interim FDG-PET analysis to identify patients with aggressive non-Hodgkin lymphoma who benefit from treatment intensification: a post-hoc analysis of the PETAL trial. Leukemia 36 (12) (2022)
Heiner Zimmermann, Christian Koenecke, Martin H Dreyling, Christiane Pott, Ulrich Dührsen, Dennis Hahn, Norbert Meidenbauer, Ingeborg A Hauser, Mathias J Rummel, Dominik Wolf, Michael Heuser, Christian Schmidt, Peter Schlattmann, Matthias Ritgen, Reiner Siebert, Ilske Oschlies, Ioannis Anagnostopoulos, Ralf U Trappe
Modified risk-stratified sequential treatment (subcutaneous rituximab with or without chemotherapy) in B-cell Post-transplant lymphoproliferative disorder (PTLD) after Solid organ transplantation (SOT): the prospective multicentre phase II PTLD-2 trial. Leukemia 36 (10) (2022)
N George Mikhaeel, Martijn W Heymans, Jakoba Johanna Eertink, Henrica C W de Vet, Ronald Boellaard, Ulrich Dührsen, Luca Ceriani, Christine Schmitz, Sanne Elisabeth Wiegers, Andreas Huettmann, Pieternella J Lugtenburg, Emanuele Zucca, Gerben J C Zwezerijnen, Otto S Hoekstra, Josée J M Zijlstra-Baalbergen, Sally F Barrington
Proposed New Dynamic Prognostic Index for Diffuse Large B-Cell Lymphoma: International Metabolic Prognostic Index. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (21) (2022)
Max S Topp, Tom van Meerten, Roch Houot, Monique C Minnema, Krimo Bouabdallah, Pieternella J Lugtenburg, Catherine Thieblemont, Martin Wermke, Kevin W Song, Irit Avivi, John G Kuruvilla, Ulrich Dührsen, Yan Zheng, Saran Vardhanabhuti, Jinghui Dong, Adrian Bot, John M Rossi, Vicki Plaks, Marika Sherman, Jenny J Kim, Anne Kerber, Marie José Kersten
Earlier corticosteroid use for adverse event management in patients receiving axicabtagene ciloleucel for large B-cell lymphoma. British journal of haematology 195 (3) (2021)
David M Kurtz, Joanne Soo, Lyron Co Ting Keh, Stefan K Alig, Jacob J Chabon, Brian J Sworder, Andre Schultz, Michael C Jin, Florian Scherer, Andrea Garofalo, Charles W Macaulay, Emily G Hamilton, Binbin Chen, Mari Olsen, Joseph G Schroers-Martin, Alexander F M Craig, Everett J Moding, Mohammad S Esfahani, Chih Long Liu, Ulrich Dührsen, Andreas Huettmann, René-Olivier Casasnovas, Jason R Westin, Mark J Roschewski, Wyndham H Wilson, Gianluca Gaidano, Davide Rossi, Maximillian Diehn, Ash A Alizadeh
Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNA. Nature biotechnology (2021)
Martina Broecker-Preuss, Nina Becher-Boveleth, Stefan P Müller, Andreas Huettmann, Christine Hanoun, Hong Grafe, Julia Richter, Wolfram Klapper, Jan Rekowski, Andreas Bockisch, Ulrich Dührsen
Impact of germline polymorphisms in genes regulating glucose uptake on positron emission tomography findings and outcome in diffuse large B-cell lymphoma: results from the PETAL trial. Journal of cancer research and clinical oncology (2021)
Helal Mohammed Mohammed Ahmed, Subbaiah Chary Nimmagadda, Yahya S Al-Matary, Maren Fiori, Tobias May, Daria Frank, Pradeep Kumar Patnana, Christian Récher, Christoph Schliemann, Jan-Henrik Mikesch, Thorsten Koenig, Frank Rosenbauer, Wolfgang Hartmann, Jan Tuckermann, Ulrich Dührsen, Wei Lanying, Martin Dugas, Bertram Opalka, Georg Lenz, Cyrus Khandanpour
Dexamethasone-mediated inhibition of Notch signalling blocks the interaction of leukaemia and mesenchymal stromal cells. British journal of haematology (2021)
Ulrich Dührsen, Mareike Tometten, Frank Kroschinsky, Arnold Ganser, Stefan Ibach, Stefanie Bertram, Andreas Huettmann
Phase I/II trial of lenalidomide, methotrexate, leucovorin, cytarabine, and rituximab (LeMLAR) in relapsed or refractory diffuse large B cell lymphoma. Blood cancer journal 11 (5) (2021)
Stefan K Alig, Charles W Macaulay, David M Kurtz, Ulrich Dührsen, Andreas Huettmann, Christine Schmitz, Michael C Jin, Brian J Sworder, Andrea Garofalo, Mohammad Shahrokh Esfahani, Barzin Y Nabet, Joanne Soo, Florian Scherer, Alexander F M Craig, René-Olivier Casasnovas, Jason R Westin, Gianluca Gaidano, Davide Rossi, Mark J Roschewski, Wyndham H Wilson, Michel Meignan, Maximilian Diehn, Ash A Alizadeh
Short Diagnosis-to-Treatment Interval Is Associated With Higher Circulating Tumor DNA Levels in Diffuse Large B-Cell Lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (23) (2021)
Patricia Johansson, Ludger Klein-Hitpass, Bettina Budeus, Matthias Kuhn, Chris Lauber, Michael Seifert, Ingo Roeder, Roman Pförtner, Martin Stuschke, Ulrich Dührsen, Anja Eckstein, Jan Dürig, Ralf Küppers
Identifying Genetic Lesions in Ocular Adnexal Extranodal Marginal Zone Lymphomas of the MALT Subtype by Whole Genome, Whole Exome and Targeted Sequencing. Cancers 12 (4) (2020)
Bettina Wagner, Ulrich Dührsen, Andreas Huettmann, Holger Nückel, Rafael Tomoya Michita, Hana Rohn, Sabine Schramm, Peter A Horn, Vera Rebmann
Genetic Variants of the NKG2C/HLA-E Receptor-Ligand Axis Are Determinants of Progression-Free Survival and Therapy Outcome in Aggressive B-Cell Lymphoma. Cancers 12 (11) (2020)
Christine Hanoun, Jan Rekowski, Stefan P Müller, Navid Farsijani, Bernd Hertenstein, Christiane Franzius, Ulla von Verschuer, Paul La Rosée, Martin Freesmeyer, Stefan Wilop, Thomas Krohn, Aruna Raghavachar, Arnold Ganser, Frank Michael Bengel, Gabriele Prange-Krex, Frank Kroschinsky, Jörg Kotzerke, Aristoteles Giagounidis, Ulrich Dührsen, Andreas Huettmann
Impact of complete surgical resection on outcome in aggressive non-Hodgkin lymphoma treated with immunochemotherapy. Cancer medicine 9 (22) (2020)
Christine Schmitz, Jan Rekowski, Stefan P Müller, Bernd Hertenstein, Christiane Franzius, Arnold Ganser, Frank M Bengel, Frank Kroschinsky, Jörg Kotzerke, Paul La Rosée, Martin Freesmeyer, Heinz-Gert Hoeffkes, Andreas Hertel, Dirk Behringer, Rolf Mesters, Matthias Weckesser, Stefan Mahlmann, Uwe Haberkorn, Uwe Martens, Gabriele Prange-Krex, Winfried Brenner, Aristoteles Giagounidis, Regina Moeller, Volker Runde, Matthias Sandmann, Hubertus Hautzel, Stefan Wilop, Thomas Krohn, Heinz Dürk, Michael Heike, Ferras Alashkar, Marcus Brinkmann, Guido Trenn, Dietmar Wacker, Christiane Kreisel-Büstgens, Helga Bernhard, Gerhard Heil, Rolf Larisch, Lars Kurch, Karl-Heinz Jöckel, Dieter Hoelzer, Wolfram Klapper, Ronald Boellaard, Ulrich Dührsen, Andreas Hüttmann
Baseline and interim PET-based outcome prediction in peripheral T-cell lymphoma: A subgroup analysis of the PETAL trial. Hematological oncology 38 (3) (2020)
Alexander Röth, Martin Bommer, Andreas Huettmann, Dörte Herich-Terhürne, Nils Kuklik, Jan Rekowski, Veronika Lenz, Hubert Schrezenmeier, Ulrich Dührsen
Eculizumab in cold agglutinin disease (DECADE): an open-label, prospective, bicentric, nonrandomized phase 2 trial. Blood advances 2 (19) (2019)
Andreas Hüttmann, Jan Rekowski, Stefan P Müller, Bernd Hertenstein, Christiane Franzius, Rolf Mesters, Matthias Weckesser, Frank Kroschinsky, Jörg Kotzerke, Arnold Ganser, Frank M Bengel, Paul La Rosée, Martin Freesmeyer, Heinz-Gert Höffkes, Andreas Hertel, Dirk Behringer, Gabriele Prange-Krex, Martin Griesshammer, Jens Holzinger, Stefan Wilop, Thomas Krohn, Aruna Raghavachar, Georg Maschmeyer, Ingo Brink, Roland Schroers, Tobias Gaska, Helga Bernhard, Aristoteles Giagounidis, Jochen Schütte, Ariane Dienst, Hubertus Hautzel, Ralph Naumann, Alfred Klein, Dennis Hahn, Gabriele Pöpperl, Matthias Grube, Jörg Marienhagen, Andreas Schwarzer, Lars Kurch, Thomas Höhler, Heike Steiniger, Holger Nückel, Thomas Südhoff, Wolfgang Römer, Marcus Brinkmann, Claudia Ose, Ferras Alashkar, Christine Schmitz, Jan Dürig, Dieter Hoelzer, Karl-Heinz Jöckel, Wolfram Klapper, Ulrich Dührsen
Six versus eight doses of rituximab in patients with aggressive B cell lymphoma receiving six cycles of CHOP: results from the "Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas" (PETAL) trial. Annals of hematology 98 (4) (2019)
Maria Sakarou, Lewin Eisele, Ulrich Dührsen, Andreas Huettmann
Efficacy of the GMALL-B-ALL/NHL2002 protocol in Burkitt leukemia/lymphoma and aggressive non-Hodgkin-lymphomas with or without CNS involvement. European journal of haematology 102 (3) (2019)
Ulrich Dührsen, Stefanie Broszeit-Luft, Annette Dieing, Andreas Lück, Piotr Porowski, Marcel Reiser, Ulrike Schwinger, Sandra Klawitter, Katja Krumm, Kathleen Jentsch-Ullrich
Rituximab maintenance therapy of follicular lymphoma in clinical practice. Cancer medicine (2018)

Ulrich Dührsen.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Ulrich Dührsen